Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $124.8M
Liabilities Breakdown FY2022
Total Liabilities: $48.9M
Asset Breakdown
Total Assets: $124.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $109.1M | 87.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $368.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $15.3M | 12.3% |
Liabilities Breakdown
Total Liabilities: $48.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $617.0K | 1.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.3M | 98.7% |